Related references
Note: Only part of the references are listed.The hepatitis B virus X protein induces paracrine activation of human hepatic stellate cells
Samuel Martin-Vilchez et al.
HEPATOLOGY (2008)
Comparative studies on expression of α-smooth muscle actin in hepatic stellate cells in chronic hepatitis B and C
Chia-Ming Chu et al.
DIGESTIVE DISEASES AND SCIENCES (2008)
Molecular mechanisms of hepatic fibrogenesis
Christopher J. Parsons et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
Role of hepatic stellate cells in fibrogenesis and the reversal of fibrosis
Tatiana Kisseleva et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: relationship to Bcl-2 family and caspase activation
A. Hamai et al.
ONCOGENE (2006)
Precision-cut fibrotic rat liver slices as a new model to test the effects of anti-fibrotic drugs in vitro
Marja van de Bovenkamp et al.
JOURNAL OF HEPATOLOGY (2006)
Oncogenic Kit signaling and therapeutic intervention in a mouse model of gastrointestinal stromal tumor
Ferdinand Rossi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
PDGF receptor tyrosine kinase inhibitor suppresses mesangial cell proliferation involving STAT3 activation
T Hirai et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2006)
Anti-fibrotic effects of thalidomide on hepatic stellate cells and dimethylnitrosamine-intoxicated rats
Lee-Won Chong et al.
JOURNAL OF BIOMEDICAL SCIENCE (2006)
Expression of c-kit receptor in human cholanglocarcinoma and in vivo treatment with imatinib mesilate in chimeric mice
Thomas Kamenz et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Reversal of hepatic fibrosis - Fact or fantasy?
SL Friedman et al.
HEPATOLOGY (2006)
Oral imatinib treatment reduces early fibrogenesis but does not prevent progression in the long term
M Neef et al.
JOURNAL OF HEPATOLOGY (2006)
Disruption of the inhibitor of apoptosis protein survivin sensitizes Bcr-abl-positive cells to STI571-induced apoptosis
ZX Wang et al.
CANCER RESEARCH (2005)
Imatinib mesylate (STI-571) attenuates liver fibrosis development in rats
H Yoshiji et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2005)
The canals of Hering might represent a target of methotrexate hepatic toxicity
P Hytiroglou et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2004)
Prostaglandin E2 inhibits transforming growth factor β1-mediated induction of collagen α1(I) in hepatic stellate cells
AY Hui et al.
JOURNAL OF HEPATOLOGY (2004)
Inhibition of T-cell responses by hepatic stellate cells via B7-H1-mediated T-cell apoptosis in mice
MC Yu et al.
HEPATOLOGY (2004)
Apicidin potentiates the imatinib-induced apoptosis of Bcr-Abl-positive human leukaemia cells by enhancing the activation of mitochondria-dependent caspase cascades
JS Kim et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Lamivudine for patients with chronic hepatitis B and advanced liver disease
YF Liaw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Conditional tetracycline-regulated expression of TGF-β1 in liver of transgenic mice leads to reversible intermediary fibrosis
E Ueberham et al.
HEPATOLOGY (2003)
The role of focal adhesion kinase-phosphatidylinositol 3-kinase-Akt signaling in hepatic stellate cell proliferation and type I collagen expression
S Reif et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Apoptosis of rat hepatic stellate cells induced by anti-focal adhesion kinase antibody
XJ Liu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2002)
Hepatic stellate cell proliferation is an early platelet-derived growth factor-mediated cellular event in rat cholestatic liver injury
N Kinnman et al.
LABORATORY INVESTIGATION (2001)
Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor.
H Joensuu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Inhibition of transforming growth factor β prevents progression of liver fibrosis and enhances hepatocyte regeneration in dimethylnitrosamine-treated rats
T Nakamura et al.
HEPATOLOGY (2000)